|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 189.49 USD | -0.40% |
|
+8.63% | +9.20% |
| 01-15 | Sonora Quest and Laboratory Sciences of Arizona announce Jennifer Erickson as CEO-elect | RE |
| 01-13 | Baird Adjusts Quest Diagnostics Price Target to $203 From $198, Maintains Neutral Rating | MT |
| Capitalization | 21.08B 18.11B 16.8B 15.7B 29.22B 1,915B 31.4B 194B 76.44B 912B 79.05B 77.43B 3,333B | P/E ratio 2025 * |
22x | P/E ratio 2026 * | 20.5x |
|---|---|---|---|---|---|
| Enterprise value | 26.44B 22.71B 21.07B 19.69B 36.66B 2,403B 39.39B 243B 95.9B 1,144B 99.17B 97.13B 4,181B | EV / Sales 2025 * |
2.41x | EV / Sales 2026 * | 2.3x |
| Free-Float |
67.83% | Yield 2025 * |
1.62% | Yield 2026 * | 1.65% |
Last Transcript: Quest Diagnostics Incorporated
| 1 day | -0.40% | ||
| 1 week | +8.63% | ||
| Current month | +9.20% | ||
| 1 month | +7.57% | ||
| 3 months | -0.01% | ||
| 6 months | +13.53% | ||
| Current year | +9.20% |
| 1 week | 175.47 |  | 190.99 |
| 1 month | 171.18 | | 190.99 |
| Current year | 171.18 | | 190.99 |
| 1 year | 150.14 | | 197.55 |
| 3 years | 119.59 | | 197.55 |
| 5 years | 113.36 | | 197.55 |
| 10 years | 59.66 | | 197.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Davis
CEO | Chief Executive Officer | 63 | 2022-02-02 |
Sam Samad
DFI | Director of Finance/CFO | 56 | 2022-07-10 |
Kristin Wallace
CMP | Compliance Officer | - | 2022-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gary Pfeiffer
BRD | Director/Board Member | 76 | 2004-11-30 |
Timothy Ring
BRD | Director/Board Member | 69 | 2011-12-06 |
James Davis
CHM | Chairman | 63 | 2023-03-31 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -4.10% | 14.84% | 303 M€ | |
| 0.00% | 2.17% | 2 M€ | |
| 0.00% | 2.05% | 5 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.40% | +8.63% | +25.32% | +30.59% | 21.08B | |
| -3.00% | -0.59% | +51.16% | +82.77% | 107B | |
| -3.39% | -2.12% | +49.37% | -10.88% | 99.78B | |
| -0.92% | -2.66% | +35.71% | +76.32% | 32.56B | |
| -0.38% | +0.31% | -9.97% | +15.01% | 24.55B | |
| +0.74% | +7.57% | +13.54% | +7.77% | 22.46B | |
| -2.27% | -2.22% | +50.34% | +268.29% | 17.29B | |
| +0.89% | -1.31% | +50.44% | +37.60% | 16.52B | |
| -2.11% | -3.45% | +8.16% | +37.23% | 12.49B | |
| -0.99% | -8.71% | -16.63% | +11.68% | 12.14B | |
| Average | -1.19% | +0.44% | +25.75% | +55.64% | 36.59B | |
| Weighted average by Cap. | -2.07% | +0.02% | +37.61% | +47.32% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 10.99B 9.44B 8.76B 8.18B 15.24B 999B 16.37B 101B 39.86B 476B 41.22B 40.38B 1,738B | 11.39B 9.78B 9.07B 8.48B 15.78B 1,035B 16.96B 105B 41.29B 493B 42.7B 41.82B 1,800B |
| Net income | 982M 843M 783M 731M 1.36B 89.23B 1.46B 9.04B 3.56B 42.49B 3.68B 3.61B 155B | 1.05B 903M 837M 782M 1.46B 95.49B 1.57B 9.68B 3.81B 45.47B 3.94B 3.86B 166B |
| Net Debt | 5.36B 4.61B 4.28B 3.99B 7.44B 487B 7.99B 49.4B 19.46B 232B 20.12B 19.71B 848B | 5.09B 4.37B 4.06B 3.79B 7.06B 463B 7.59B 46.9B 18.47B 220B 19.1B 18.71B 805B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-16 | 189.49 $ | -0.40% | 1,132,571 |
| 26-01-15 | 190.26 $ | +1.87% | 1,245,699 |
| 26-01-14 | 186.77 $ | +3.78% | 1,498,946 |
| 26-01-13 | 179.96 $ | +2.28% | 1,069,588 |
| 26-01-12 | 175.94 $ | +0.86% | 695,248 |
Delayed Quote Nyse, January 16, 2026 at 04:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DGX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition